Skip to main content

Diabetes, Type 2 News

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation

WEDNESDAY, May 29, 2024 – Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research...

Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes

FRIDAY, May 24, 2024 – Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug significantly reduces the...

Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds

THURSDAY, May 23, 2024 – Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than...

Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans

WEDNESDAY, May 22, 2024 – The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report...

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults

WEDNESDAY, May 22, 2024 – For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research letter published...

Men Are More Debilitated by Diabetes Than Women

FRIDAY, May 17, 2024 – Men are more vulnerable than women to the debilitating effects of diabetes, a new long-term study finds. Overall rates of diabetes are similar between men and women, according...

Men Face More Diabetes Complications Than Women

FRIDAY, May 17, 2024 – Men with diabetes have a greater risk for complications than women, irrespective of diabetes duration, according to a study published online May 16 in the Journal of ...

Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist

TUESDAY, May 14, 2024 – One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to...

AI-Informed Health App Aids Diabetes Outcomes

WEDNSDAY, May 15, 2024 – Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular disease (ASCVD) risk, according to a study...

Fat-Enlarged Axillary Nodes on Mammogram May Indicate Higher CVD Risk

TUESDAY, May 14, 2024 – Fat-enlarged axillary nodes on screening mammograms can predict the risk for cardiovascular disease (CVD), according to a study presented at the annual meeting of the...

Researchers Quantify the Risk for Diabetes After Gestational Diabetes

THURSDAY, May 9, 2024 – Gestational diabetes is associated with an increased risk for subsequent diabetes, with higher risk for gestational diabetes in second pregnancy and in both first and second...

More Than 200 Insulin Pump Users Injured After App Causes Malfunction

THURSDAY, May 9, 2024 – The U.S. Food and Drug Administration has issued a Class 1 recall – its most urgent kind – for an IOS app linked to a specific kind of insulin pump used by people with...

Neuropathy Nerve Damage Often Goes Undiagnosed

THURSDAY, May 9, 2024 — Though it is a widespread disorder, neuropathy often goes undiagnosed, new research shows, leaving many people at risk of falls, infection and even amputation. Neuropathy is n...

Exposure to Food Additive Emulsifiers Linked to Risk for Type 2 Diabetes

MONDAY, May 6, 2024 – Exposure to food additive emulsifiers is associated with an increased risk for type 2 diabetes, according to a study published in the May issue of The Lancet Diabetes &...

Diabetes Increases Risk for Functional Limitations in Older Adults

FRIDAY, May 3, 2024 – Older adults with diabetes are more likely to develop functional limitations than adults without diabetes, according to a study published online April 16 in the Canadian...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diabetes Mellitus

Related drug support groups

metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Humalog, Novolog, Jardiance, Lantus Solostar, Farxiga, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, liraglutide, Invokana, Glucophage, Humulin N, insulin degludec